InvestorsHub Logo
Followers 2
Posts 442
Boards Moderated 0
Alias Born 04/18/2007

Re: greens12 post# 28107

Saturday, 01/25/2020 12:47:23 PM

Saturday, January 25, 2020 12:47:23 PM

Post# of 43784
From S-8

L.E.A.P.S. (Ligand Epitope Antigen Presentation System) technology, or LEAPS, with two investigational therapies, CEL-2000 and CEL-4000, vaccine product candidates under development for the potential treatment of rheumatoid arthritis, and LEAPS-H1N1-DC, a product candidate under development for the potential treatment of pandemic influenza in hospitalized patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News